103 filings
8-K
ALPN
Alpine Immune Sciences Inc
18 Mar 24
Alpine Immune Sciences Provides Corporate Update and Full Year 2023 Financial Results
4:19pm
8-K
ALPN
Alpine Immune Sciences Inc
7 Feb 24
Unregistered Sales of Equity Securities
4:12pm
8-K
ALPN
Alpine Immune Sciences Inc
5 Jan 24
Departure of Directors or Certain Officers
4:45pm
8-K
ALPN
Alpine Immune Sciences Inc
21 Dec 23
Alpine Immune Sciences Announces Amendment of Acazicolcept Option and License Agreement with AbbVie
4:23pm
8-K
ALPN
Alpine Immune Sciences Inc
14 Nov 23
Alpine Immune Sciences Reports Third Quarter 2023 Financial Results
12:00am
8-K
qbtsk2 dtrmlo3f1y8i
7 Nov 23
Entry into a Material Definitive Agreement
8:18pm
8-K
vfi48
6 Nov 23
Results of Operations and Financial Condition
6:02am
8-K
85plwhin
2 Nov 23
Other Events
9:12am
8-K
hj30ij5c1ipb0upirvj6
14 Aug 23
Alpine Immune Sciences Reports Second Quarter 2023 Financial Results
4:22pm
8-K
981l0
14 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
ytl5okv
11 May 23
Alpine Immune Sciences Reports First Quarter 2023 Financial Results
4:21pm
8-K
hapm1c
28 Apr 23
Entry into a Material Definitive Agreement
5:03pm
8-K
kxysmr6xaarpuv
23 Mar 23
Alpine Immune Sciences Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
4:34pm
8-K
nk6rdds655
26 Jan 23
Amendments to Articles of Incorporation or Bylaws
4:13pm
8-K
j92kubp r2r
14 Nov 22
Alpine Immune Sciences Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:25pm
8-K
3walfxi
24 Oct 22
Other Events
8:09am
8-K
i4mo00gp gi
21 Sep 22
Termination of a Material Definitive Agreement
5:23pm
8-K
0iej8sx kmcuq
12 Sep 22
Other Events
4:19pm
8-K
uuj8 rrwc61kl
11 Aug 22
Alpine Immune Sciences Provides Corporate Update and Reports Second Quarter 2022 Financial Results
4:11pm
8-K
12awu 6x4ult26rvt7
9 Aug 22
Regulation FD Disclosure
6:18am